The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, two-cohort study of neoadjuvant chemotherapy plus tislelizumab ± bevacizumab followed by hypofractionated radiotherapy, concurrent chemotherapy, and consolidative immunotherapy in locally advanced non-small cell lung cancer (GASTO-1086).
 
DaQuan Wang
No Relationships to Disclose
 
Bo Qiu
No Relationships to Disclose
 
FangJie Liu
No Relationships to Disclose
 
Yiwen Mo
No Relationships to Disclose
 
Wen-zhuo He
No Relationships to Disclose
 
JinYu Guo
No Relationships to Disclose
 
YingYi Zou
No Relationships to Disclose
 
Ying-Ying Hu
No Relationships to Disclose
 
Liang-Ping Xia
No Relationships to Disclose
 
QianWen Liu
No Relationships to Disclose
 
Hui Liu
No Relationships to Disclose